Results 81 to 90 of about 6,390 (207)
Safety of an Intravitreal Bevacizumab Biosimilar (MVASI)
Clinical &Experimental Ophthalmology, Volume 53, Issue 5, Page 523-528, July 2025.ABSTRACT Background Intravitreal bevacizumab has been used off‐label to treat multiple ocular conditions for almost two decades. Reference bevacizumab, Avastin, was discontinued in Australia in 2021. A bevacizumab biosimilar, MVASI, was approved by the Therapeutic Goods Administration for the treatment of metastatic cancer in 2020.
Hanru Wang +8 more
wiley +1 more source
Optimization and regeneration kinetics of lymphatic-specific photodynamic therapy in the mouse dermis. [PDF]
, 2013 Lymphatic vessels transport fluid, antigens, and immune cells to the lymph nodes to orchestrate adaptive immunity and maintain peripheral tolerance. Lymphangiogenesis has been associated with inflammation, cancer metastasis, autoimmunity, tolerance and ...
Golab, J. +6 more
core +1 more source
Advanced Intelligent Systems, Volume 7, Issue 4, April 2025.The proposed artificial intelligence model, cross‐subject meta‐transfer learning, enables the automatic detection of vitreoretinal lymphoma (VRL) on optical coherence tomography images among 16 retinal diseases and conditions. This study provides an innovative solution to assist in the VRL diagnosis in real‐world clinical implementation, showing ...
Aidi Lin +23 more
wiley +1 more source
Elastin Variants in Two Angiographic PCV Subtypes [PDF]
, 2021 Objective To compare the association of elastin (ELN) gene variants between two different angiographic phenotypes of polypoidal choroidal vasculopathy (PCV). Methods We included 411 treatment-naïve PCV patients and 350 controls in the present study.
Honda, Shigeru +5 more
core
Polypoidal choroidal vasculopathy: a comprehensive clinical update
Therapeutic Advances in Ophthalmology, 2019 Polypoidal choroidal vasculopathy as a disease is yet to be comprehended completely. The clinical features consisting of huge serosanguineous retinal pigment epithelial and neurosensory layer detachments, although unique may closely mimick neovascular ...
Atul Kumar +8 more
doaj +1 more source
PACHYCHOROID: an inherited condition? [PDF]
, 2015 PURPOSE: Thick choroid (pachychoroid) is associated with central serous chorioretinopathy (CSC), but whether pachychoroid is inherited is unknown. METHODS: In a prospective observational study, first- or second-degree relatives (16 individuals) of 5 ...
Behar-Cohen, F. +3 more
core +1 more source
Ophthalmic and Physiological Optics, Volume 45, Issue 2, Page 480-493, March 2025.Abstract Purpose Visual acuity (VA) is a primary outcome measure that defines the success of clinical interventions for retinal diseases such as age‐related macular degeneration (AMD) or diabetic macular oedema (DME). These conditions can lead to the presence of subretinal fluid, causing substantial photoreceptor layer elevation. Hyperopic defocus then
Vamsi Parimi +5 more
wiley +1 more source
Novel Retinal Imaging Technologies [PDF]
, 2017 Newly-developed imaging techniques show extensive promise and potential to improve early detection, accurate diagnosis, and management of retinal diseases.
Li Y, Xia X, Paulus YM
core +1 more source
Case Reports in Ophthalmological Medicine, Volume 2025, Issue 1, 2025.Massive subretinal hemorrhage secondary to neovascular age–related macular degeneration (nAMD) is relatively uncommon, and reports of secondary angle closure glaucoma associated with such hemorrhage are even rarer. We report a case of a 93‐year‐old woman with a history of nAMD who developed this condition, along with a review of the relevant literature.
Kosuke Nagaoka +4 more
wiley +1 more source
Current management strategy of polypoidal choroidal vasculopathy
Indian Journal of Ophthalmology, 2018 Polypoidal choroidal vasculopathy (PCV) is a retinal disorder commonly found in Asians presenting as neovascular age-related macular degeneration and is characterized by serous macular detachment, serous or hemorrhagic pigment epithelial detachment ...
Christine P S Ho, Timothy Y Y Lai
doaj +1 more source